Paediatric Ophthalmology Unit, Schneider Children's Medical Centre of Israel, Sackler Faculty of Medicine, Tel Aviv University, Petah Tiqwa, Israel.
Eye (Lond). 2009 Jun;23(6):1302-7. doi: 10.1038/eye.2008.300. Epub 2008 Nov 7.
To evaluate the effect of combined intralesional and sub-Tenon's administration of corticosteroids for the treatment of refractory periocular and orbital capillary haemangioma in a retrospective, non-comparative study.
Seven infants with resistant periorbital and orbital capillary haemangioma who attended our tertiary centre from 2000 to 2005 were treated with an intralesional injection of a mixture of betamethasone 6 mg/cc and triamcinolone 10 mg/cc, by body weight, together with sub-Tenon's infusion of betamethasone 6 mg/cc and triamcinolone 40 mg/cc of a volume of 1 cc, close to the orbital lesion, in the same session. Visual axis, proptosis, pre- and post-treatment changes in four refractive parameters, and parental satisfaction were evaluated.
None of the babies had proptosis or visual axis obstruction after treatment. Mean spherical power decreased by 22.7% (P=0.06). Mean spherical equivalent decreased in 34%, but the difference was not statistically significant (P=0.09). No early or late ocular side effects were observed. Mean intraocular pressure results were normal before and immediately after treatment, and during the follow-up period. Parental satisfaction score during follow-up was 9/10. Mean time to improvement was 96.43+/-58.3 days.
Combined local corticosteroid administration by posterior sub-Tenon's infusion and intralesional injection in babies with extensive capillary haemangioma is associated with a satisfactory anatomical and functional outcome and there were no ophthalmic side effects.
在一项回顾性、非对照研究中,评估皮质类固醇联合局部和经Tenon 囊下给药治疗难治性眶周和眼眶毛细血管血管瘤的效果。
2000 年至 2005 年,我们的三级中心收治了 7 例抵抗性眶周和眼眶毛细血管血管瘤的婴儿,采用每 cc 含 6mg 倍他米松和 10mg 曲安奈德的混合药物进行局部注射,根据体重给药,同时在同一部位进行经 Tenon 囊下注射每 cc 含 6mg 倍他米松和 40mg 曲安奈德的药物,剂量接近眼眶病变。评估视轴、眼球突出度、治疗前后 4 项屈光参数的变化以及家长满意度。
治疗后,没有婴儿出现眼球突出或视轴阻塞。平均球镜屈光度降低 22.7%(P=0.06)。平均等效球镜屈光度降低 34%,但差异无统计学意义(P=0.09)。未观察到早期或晚期眼部副作用。治疗前后及随访期间平均眼压结果正常。随访期间家长满意度评分为 9/10。改善的平均时间为 96.43+/-58.3 天。
对于广泛毛细血管血管瘤的婴儿,采用经 Tenon 囊下输注和局部注射联合皮质类固醇给药,可获得令人满意的解剖和功能结果,且无眼部副作用。